DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
von Minckwitz G, Huang CS, Mano MS. et al.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med 2018;
DOI: 10.1056/NEJMoa1814017.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.